APA aipamena

Siegel, D. S., Schiller, G. J., Samaras, C., Sebag, M., Berdeja, J., Ganguly, S., . . . Bahlis, N. J. (2020). Pomalidomide, dexamethasone, and daratumumab in relapsed refractory multiple myeloma after lenalidomide treatment. Leukemia.

Chicago Style aipamena

Siegel, David S., et al. "Pomalidomide, Dexamethasone, and Daratumumab in Relapsed Refractory Multiple Myeloma After Lenalidomide Treatment." Leukemia 2020.

MLA aipamena

Siegel, David S., et al. "Pomalidomide, Dexamethasone, and Daratumumab in Relapsed Refractory Multiple Myeloma After Lenalidomide Treatment." Leukemia 2020.